AMPH Amphastar Pharmaceuticals Inc.

19.99
-0.09  -0%
Previous Close 20.08
Open 19.96
Price To Book 2.41
Market Cap 938,291,160
Shares 46,938,027
Volume 158,114
Short Ratio
Av. Daily Volume 240,840
Stock charts supplied by TradingView

NewsSee all news

  1. Amphastar Pharmaceuticals to Present at the 31st Annual Piper Jaffray Healthcare Conference

    RANCHO CUCAMONGA, Calif., Nov. 27, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President and Bill Peters, CFO will be presenting at the 31st Annual Piper

  2. Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference

    RANCHO CUCAMONGA, Calif., Nov. 15, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President will be presenting at the Jefferies London Healthcare Conference

  3. Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2019

    Reports Net Revenues of $80.1 Million for the Three Months Ended September 30, 2019 RANCHO CUCAMONGA, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the

  4. Amphastar Pharmaceuticals to Present at the Wells Fargo 2019 Healthcare Conference

    RANCHO CUCAMONGA, Calif., Aug. 29, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President, and Bill Peters, CFO, will be presenting at the Wells Fargo 2019

Drug Information

Drug catalyst information is displayed when you hover over / tap on the stage bar graph.

Albuterol DPI
Asthma
CRL announced February 21, 2017.
Naloxone Intranasal
Opioid overdose
CRL issued December 27, 2016.
Primatene Mist (epinephrine inhalation aerosol)
Asthma

Latest News

  1. Amphastar Pharmaceuticals to Present at the 31st Annual Piper Jaffray Healthcare Conference

    RANCHO CUCAMONGA, Calif., Nov. 27, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President and Bill Peters, CFO will be presenting at the 31st Annual Piper

  2. Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference

    RANCHO CUCAMONGA, Calif., Nov. 15, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President will be presenting at the Jefferies London Healthcare Conference

  3. Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2019

    Reports Net Revenues of $80.1 Million for the Three Months Ended September 30, 2019 RANCHO CUCAMONGA, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the

  4. Amphastar Pharmaceuticals to Present at the Wells Fargo 2019 Healthcare Conference

    RANCHO CUCAMONGA, Calif., Aug. 29, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President, and Bill Peters, CFO, will be presenting at the Wells Fargo 2019